Functional Gains From Novel Agent for OHCM, Top-line Results Functional Gains From Novel Agent for OHCM, Top-line Results

Patients with obstructive hypertrophic cardiomyopathy showed consistent hemodynamic and functional gains on mavacamten, which targets cardiac myosin, in top-line results released by MyoKardia.Medscape Medical News
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news